These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6496516)

  • 1. Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
    Cheung YW; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1984 Sep; 41(9):1802-6. PubMed ID: 6496516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
    Cradock JC; Kleinman LM; Rahman A
    Am J Hosp Pharm; 1978 Apr; 35(4):402-6. PubMed ID: 25579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of intravenous admixtures of doxorubicin and vincristine.
    Beijnen JH; Neef C; Meuwissen OJ; Rutten JJ; Rosing H; Underberg WJ
    Am J Hosp Pharm; 1986 Dec; 43(12):3022-7. PubMed ID: 3812509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droperidol stability in intravenous admixtures.
    Ray JB; Newton DW; Nye MT; Leet WA
    Am J Hosp Pharm; 1983 Jan; 40(1):94-7. PubMed ID: 6823997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
    de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
    J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
    Galante LJ; Stewart JT; Warren FW; Johnson SM; Duncan R
    Am J Hosp Pharm; 1990 Jul; 47(7):1580-4. PubMed ID: 2368751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Michelini TJ; McMahon RE
    Am J Hosp Pharm; 1987 Jul; 44(7):1620-4. PubMed ID: 3307397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.
    Deans KW; Lang JR; Smith DE
    Am J Hosp Pharm; 1982 Oct; 39(10):1681-4. PubMed ID: 6983297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of esmolol hydrochloride in intravenous solutions.
    Baaske DM; Dykstra SD; Wagenknecht DM; Karnatz NN
    Am J Hosp Pharm; 1994 Nov; 51(21):2693-6. PubMed ID: 7856582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
    Bell RG; Lipford LC; Massanari MJ; Riley CM
    Am J Hosp Pharm; 1986 Jun; 43(6):1444-53. PubMed ID: 3728479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
    Gardella LA; Zaroslinski JF; Possley LH
    Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of azacitidine in infusion fluids.
    Cheung YW; Vishnuvajjala BR; Morris NL; Flora KP
    Am J Hosp Pharm; 1984 Jun; 41(6):1156-9. PubMed ID: 6204528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of an ofloxacin injection in various infusion fluids.
    Bornstein M; Kao SH; Mercorelli M; Verma S
    Am J Hosp Pharm; 1992 Nov; 49(11):2756-60. PubMed ID: 1335206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of mitomycin admixtures.
    Quebbeman EJ; Hoffman NE; Ausman RK; Hamid AA
    Am J Hosp Pharm; 1985 Aug; 42(8):1750-4. PubMed ID: 4036973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.